Magicplex TM Sepsis real-time test for the rapid diagnosis of bloodstream infections in adults
Authors:
- Yuliya ZboromyrskaYZYuliya Zboromyrska
- Catia CillónizCatia Cillóniz
- Nazaret Cobos-TriguerosNCNazaret Cobos-Trigueros
- Manel AlmelaMAManel Almela
- Juan Carlos HurtadoJHJuan Carlos Hurtado
- Andrea VergaraAVAndrea Vergara
- Caterina MataCMCaterina Mata
- Alex SorianoASAlex Soriano
- Josep MensaJMJosep Mensa
- Francesc MarcoFMFrancesc Marco
- Jordi VilaJordi Vila
Preprint
Abstract
Sepsis is a serious health condition worldwide, affecting more than 30 million people globally each year. In 2017, the World Health Organization (WHO) adopted a resolution on sepsis: “improving the prevention, diagnosis and clinical management of sepsis”, with the aim of improving early diagnosis, management and prevention to save lives. Blood culture (BC) is generally used to diagnose sepsis because of the low quantity of microbes occurring in the blood during such infections. However, approximately 50% of bloodstream infections (BSI) give negative BC, this figure being higher for sepsis, which delays the start of appropriate antimicrobial therapy. This prospective study evaluated a multiplex real-time polymerase chain reaction, the Magicplex TM Sepsis test (MP), for the detection of pathogens from whole blood, comparing it to routine BC. We analysed 809 blood samples from 636 adult patients, with 132/809 (16.3%) of the samples positive for one or more relevant microorganism according to BC and/or MP. The sensitivity and specificity of MP were 29% and 95%, respectively, while the level of agreement between BC and MP was 87%. The rate of contaminated samples was higher for BC (10%) than MP (4.8%) ( P < 0.001). Patients with only MP-positive samples were more likely to be on antimicrobial treatment (47%) than those with only BC-positive samples (18%) ( P = 0.002). In summary, the MP test reduces the time taken to identify the microbial pathogen, improving the diagnosis of BSI in patients on antibiotic treatment.Keywords
All Related Versions
- Published version: Frontiers in Cellular and Infection Microbiology, 9, 56.
This publication has 19 references indexed in Scilit:
- Emerging Technologies for Molecular Diagnosis of SepsisClinical Microbiology Reviews, 2018
- Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First HourCritical Care Medicine, 2014
- Comparison of Pathogen DNA Isolation Methods from Large Volumes of Whole Blood to Improve Molecular Diagnosis of Bloodstream InfectionsPLOS ONE, 2013
- Comparison of two molecular assays with conventional blood culture for diagnosis of sepsisJournal of Microbiological Methods, 2013
- Evaluation of a Polymerase Chain Reaction Assay for Pathogen Detection in Septic Patients under Routine Condition: An Observational StudyPLOS ONE, 2012
- Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsisWiener klinische Wochenschrift, 2012
- Diagnosis of Bacteremia in Whole-Blood Samples by Use of a Commercial Universal 16S rRNA Gene-Based PCR and Sequence AnalysisJournal of Clinical Microbiology, 2009
- Molecular diagnosis of bloodstream infections caused by non-cultivable bacteriaInternational Journal of Antimicrobial Agents, 2007
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Quantitative aspects of septicemiaClinical Microbiology Reviews, 1990